Laserfiche WebLink
Exhibit liB": §200.331 requirements for pass-through entities <br />-Is this a subaward? Yes <br />i Federal Award Identification 1U58DP005531-01 <br />ii Subrecipient Name Kitt itas Co unty Public Hea lt h De part me nt <br />iii Subrecipient DUNS # 0 1-020-2547 <br />Iv Federal Award Identification # 1U58DP005531-01 <br />V Federal Award Date 9/30/2014 <br />Subaward Period of January 1, 2015 -September 29,2016 (includes year 1 <br />Vi (yrl) Performance Start and End Date carryover funds) <br />Amount of Federal Funds <br />Vii (yrl) Obligated by this action $182,643 (includes year 1 carryover funds) <br />Total Amount of Federal Funds <br />Viii (yrl) Obligated to the subrecipient $2 0,20 3 (Includes Year 1 Carry over Funds) <br />Subaward Period of <br />Vi (yr2) Performance Start and End Date September 30, 2015 -September 29,2016 (year 2 Funds) <br />Amount of Federal Funds <br />Vii (yr2) Obligated by this action $182,643 (Year 2 Funds) <br />Total Amount of Federal Funds <br />Viii (yr2) Obligated to the subrecipient $2 0,500 (Year 2 Funds) <br />Federal award project State and Local Public Health Actions to Prevent Obesity, <br />Ix description Diabetes, Heart Disease and Stroke financed soley by 2014 <br />Prevention and Public Health Funds <br />x (a) Name of Federal awarding <br />agency Department of Health and Human Services, CDC <br />x (b) Pass-through entity Department of Health <br />Contact information for <br />x (c) awarding official Grant County Health District <br />CFDA # (note dollar amount <br />awarded for this CFDA# in "vii" <br />xi above 93.757 <br />Is the award for R&D (research <br />xii and development)? No <br />xiii Indirect Cost Rate for <br />Subrecipient Award 22% of sa lar ies & benefits <br />Interagency Agreement -Kittitas Amendment#l <br />11/20/15 <br />Page 9